This site uses cookies to measure how you use the website so it can be updated and improved based on your needs and also uses cookies to help remember the notifications you’ve seen, like this one, so that we don’t show them to you again. If you could also tell us a little bit about yourself, this information will help us understand how we can support you better and make this site even easier for you to use and navigate.

Angiotensin-converting enzyme inhibitors and Alzheimer’s disease progression in older adults: results from the Réseau sur la Maladie d’Alzheimer Français cohort


Soto, Maria E., Abellan van Kan, Gabor, Nourhashemi, Fati, Gillette-Guyonnet, Sophie, Cesari, Matteo, Cantet, Christelle, Rolland, Yves, Vellas, Bruno


Journal Of The American Geriatrics Society, Volume: 61, No.: 9, Pages.: 1482-1488

Year of Publication



Objectives: To assess whether angiotensin-converting enzyme inhibitor (ACE-I) treatment is associated with less cognitive decline in older adults with Alzheimer’s disease (AD) than in those using other hypertensive or no drugs.; Design: Four-year prospective multicenter cohort study with a biannual assessment.; Setting: Memory clinics from 16 university hospitals in France.; Participants: Community-dwelling older adults with mild to moderate AD (N = 616).; Measurements: Participants were stratified into four groups according to type and duration of antihypertensive drug treatment. Cognitive decline was assessed using the Mini-Mental State Examination (MMSE). Linear mixed-effects models were used to assess differences in decline in MMSE score between the four groups. Hypertension at each visit was included in the model.; Results: Sixty-one participants had used ACE-Is continuously, 57 had used them intermittently, 189 had used other antihypertensive drugs, and 309 never used any antihypertensive drugs. Continuous ACE-Is users had a 4-year decline in MMSE of 6.4 ± 1.6 points (P < .001), intermittent ACE-Is users of 7.9 ± 1.1 points (P < .001), continuous or intermittent users of other antihypertensive drugs of 8.8 ± 0.7 points (P < .001), and never-users of 10.2 ± 0.6 points (P < .001). MMSE decline between the four groups was significantly different (adjusted P = .02). In subgroup analysis, the 118 (19.2%) participants who had continuously or intermittently used ACE-Is had a significant difference in 4-year MMSE decline from the 498 (80.8%) who had never used ACE-Is (7.5 ± 0.9 vs 9.7 ± 0.4; P = .03).; Conclusion: The use of ACE-Is in older adults with AD is associated with a slower rate of cognitive decline independent of hypertension. Future research is needed to explore the role of ACE-Is in long-term AD progression.; © 2013, Copyright the Authors Journal compilation © 2013, The American Geriatrics Society.

Bibtex Citation

@article{Soto_2013, doi = {10.1111/jgs.12415}, url = {}, year = 2013, month = {sep}, publisher = {Wiley-Blackwell}, volume = {61}, number = {9}, pages = {1482--1488}, author = {Maria E. Soto and Gabor Abellan van Kan and Fati Nourhashemi and Sophie Gillette-Guyonnet and Matteo Cesari and Christelle Cantet and Yves Rolland and Bruno Vellas}, title = {Angiotensin-Converting Enzyme Inhibitors and Alzheimer{textquotesingle}s Disease Progression in Older Adults: Results from the R{'{e}}seau sur la Maladie d{textquotesingle}Alzheimer Fran{c{c}}ais Cohort}, journal = {Journal of the American Geriatrics Society} }


acei, aged, alzheimer disease, alzheimer’s disease, angiotensinconverting enzymeinhibitors, cognition, complications, disease progression, drug effects, drug therapy, enzyme, epidemiology, etiology, female, france, humans, incidence, inhibitor, male, methods, mild cognitive impairment, neuropsychological tests, older adults, prevention & control, prospective studies, psychology, risk assessment, risk factors, therapeutic use, treatment

Countries of Study


Types of Dementia

Alzheimer’s Disease

Types of Study

Cohort Study

Type of Outcomes



Specialist Dementia Centre Care / Memory Clinic

Type of Interventions

Pharmaceutical Interventions

Pharmaceutical Interventions